Intervention

telmisartan

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting0

Common conditions10

Lead sponsors shown6

Clinical trials

12 shown

Efficacy and Safety of Telmisartan Compared With LosartanNCT06431477 · 2023-04-19

Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With HypertensionNCT03956823 · 2019-08-01

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe HypertensionNCT00860262 · 2009-03-01

Regulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsNCT00560430 · 2007-11-01

Filtered Trial for Telmisartan 40mg Non-responderNCT00550953 · 2007-10-01

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in DiabetesNCT00599885 · 2007-09-01

Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaNCT00316095 · 2006-04-01

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)NCT00168857 · 2003-07-09

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure RiseNCT00946829 · 2003-01-01

SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk PatientsNCT00274105 · 2001-03-01

Telmisartan in Haemodialysis Patients With Chronic Heart FailureNCT00490958 · 1999-01-01

DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilNCT00274118 · 1997-07-01

Common conditions

Hypertension11 Diabetic Nephropathies2 Coronary Arteriosclerosis1 Coronary Artery Disease1 Diabetes1 Diabetes Mellitus, Type 21 Dyslipidemias1 Heart Failure, Congestive1 Hypertriglyceridemia1 Metabolic Syndrome1

Leading sponsors

Boehringer Ingelheim7 Chong Kun Dang Pharmaceutical1 First Affiliated Hospital Xi'an Jiaotong University1 Korea University Anam Hospital1 Ludwig-Maximilians - University of Munich1 University of Campania Luigi Vanvitelli1

Trial status mix

COMPLETED9

UNKNOWN2

TERMINATED1

Phase mix

PHASE35

PHASE45

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.